Lepu Medical Technology (Beijing) Co. Ltd.

Company Snapshot

Founded: 1999
Entity Type: Public
Employees: 8,689
Region: China
Revenue: $901.8 Millions
Revenue Year: 2025
Segment: Medical devices
Headquarter: Beijing, China
Key Geographics: Asia, Europe, North America, Middle-East
Corporate Address: Building 3, No. 37 Chaoqian Road, Changping District, Beijing, China Tel. +86-10-8012-0666 www.lepumedical.com

Company Overview

Founded in 1999, Lepu Medical Technology (Beijing) Co., Ltd. specializes in the development, manufacturing, and marketing of advanced medical devices and equipment. The company has become a global leader in structural heart diseases, cardiac rhythm management, cardiovascular interventions, in vitro diagnostics, anesthesia and critical care, and general surgery. Its product range includes dilatation balloon catheters, coronary stents, interventional accessories, occlusion devices, mechanical heart valves, pacemakers, electrophysiology catheters, in vitro diagnostic equipment and biomarkers, DSA systems, and surgical staplers. In 2009, Lepu Medical successfully went public and was listed on the Chinext Shenzhen Stock Exchange (stock code: 300003).

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Lepu Medical Technology (Beijing) Co. Ltd. In Reports

Pacemakers: Global Markets

BCC Research detailed report on pacemaker market revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period from 2025 through 2030.

Global Colorectal Cancer Screening and Diagnostics Market

BCC Research Report: Dive into Colorectal Cancer Screening and Diagnostics Market estimates, data is provided for 2021 and 2022 as historical years, 2023 as the base year, and forecasts extend through 2029.

Advanced Orthopedic Technologies, Implants and Regenerative Products

According to BCC Research Report global market for advanced orthopedic market is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028.

Company's Business Segments

  • Medical devices : This business focuses on the entire lifecycle of cardiovascular disease diagnosis and treatment, while the innovative transformation business centers on neuromodulation and brain-computer interfaces, establishing a development pattern for medical devices.
  • Pharmaceuticals : This sector is primarily focused on cardiovascular diseases and metabolic disorders medications.
  • Medical services and health manage : This business provides comprehensive life-cycle care for patients with cardiovascular diseases, while the innovative transformation business focuses on dermatology pharmaceuticals and medical devices, creating a new growth driver for consumer healthcare that operates outside the national medical insurance system and features independent pricing.

Applications/End User Industries

  • Healthcare
  • Medical Devices
  • Medicines
  • Diagnostics
  • Medical Services
  • Telehealth
  • Biotechnology Industries
AI Sentiment